Literature DB >> 33662628

Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients.

Zheng Zhao1, Ke-Nan Zhang1, Qiangwei Wang2, Guanzhang Li1, Fan Zeng1, Ying Zhang1, Fan Wu1, Ruichao Chai1, Zheng Wang3, Chuanbao Zhang3, Wei Zhang3, Zhaoshi Bao4, Tao Jiang5.   

Abstract

Gliomas are the most common and malignant intracranial tumors in adults. Recent studies have revealed the significance of functional genomics for glioma pathophysiological studies and treatments. However, access to comprehensive genomic data and analytical platforms is often limited. Here, we developed the Chinese Glioma Genome Atlas (CGGA), a user-friendly data portal for the storage and interactive exploration of cross-omics data, including nearly 2000 primary and recurrent glioma samples from Chinese cohort. Currently, open access is provided to whole-exome sequencing data (286 samples), mRNA sequencing (1018 samples) and microarray data (301 samples), DNA methylation microarray data (159 samples), and microRNA microarray data (198 samples), and to detailed clinical information (age, gender, chemoradiotherapy status, WHO grade, histological type, critical molecular pathological information, and survival data). In addition, we have developed several tools for users to analyze the mutation profiles, mRNA/microRNA expression, and DNA methylation profiles, and to perform survival and gene correlation analyses of specific glioma subtypes. This database removes the barriers for researchers, providing rapid and convenient access to high-quality functional genomic data resources for biological studies and clinical applications. CGGA is available at http://www.cgga.org.cn.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Chinese Glioma Genome Atlas; Chinese cohort; Database; Functional genomics; Glioma

Year:  2021        PMID: 33662628     DOI: 10.1016/j.gpb.2020.10.005

Source DB:  PubMed          Journal:  Genomics Proteomics Bioinformatics        ISSN: 1672-0229            Impact factor:   7.691


  119 in total

1.  Non-Canonical NF-κB Signaling Stratifies LGG into Subtypes with Distinct Molecular and Cellular Characteristic and Survival Expectancy.

Authors:  Minhua Lin; Tianxiang Huang; Xuan Wang; Xuenan Li; Jingjiao Ma; Lan Su; Jun Wu
Journal:  Int J Gen Med       Date:  2022-04-05

2.  Metabolic-related gene pairs signature analysis identifies ABCA1 expression levels on tumor-associated macrophages as a prognostic biomarker in primary IDHWT glioblastoma.

Authors:  Shiqun Wang; Lu Li; Shuguang Zuo; Lingkai Kong; Jiwu Wei; Jie Dong
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

3.  The current state of glioma data registries.

Authors:  Alexander G Yearley; Julian Bryan Iorgulescu; Ennio Antonio Chiocca; Pier Paolo Peruzzi; Timothy R Smith; David A Reardon; Michael A Mooney
Journal:  Neurooncol Adv       Date:  2022-06-24

4.  Integrative analysis of CBR1 as a prognostic factor associated with IDH-mutant glioblastoma in the Chinese population.

Authors:  Pengxiang Ji; Xueshi Shan; Jian Wang; Ping Zhang; Zhan Cai
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

5.  Tripartite motif-containing 25 facilitates immunosuppression and inhibits apoptosis of glioma via activating NF-κB.

Authors:  Mao-Xu Ge; Yi-Kang Shi; Dong Liu
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-20

6.  LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma.

Authors:  Dan Liu; Yue Wan; Ning Qu; Qiang Fu; Chao Liang; Lingda Zeng; Yang Yang
Journal:  Front Public Health       Date:  2022-07-06

7.  Elevated RECQL1 expression predicts poor prognosis and associates with tumor immune infiltration in low-grade glioma.

Authors:  Guiyuan Wang; Yulin Cen; Celi Wang; Wei Xiang; Shenjie Li; Yang Ming; Ligang Chen; Jie Zhou
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

8.  TWIST1 methylation by SETD6 selectively antagonizes LINC-PINT expression in glioma.

Authors:  Lee Admoni-Elisha; Tzofit Elbaz; Anand Chopra; Guy Shapira; Mark T Bedford; Christopher J Fry; Noam Shomron; Kyle Biggar; Michal Feldman; Dan Levy
Journal:  Nucleic Acids Res       Date:  2022-06-13       Impact factor: 19.160

9.  T-Cell Exhaustion Status Under High and Low Levels of Hypoxia-Inducible Factor 1α Expression in Glioma.

Authors:  Shuai Liu; Xing Liu; Chuanbao Zhang; Wei Shan; Xiaoguang Qiu
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

10.  Comprehensive Bioinformatics Analysis of mRNA Expression Profiles and Identification of a miRNA-mRNA Network Associated with the Pathogenesis of Low-Grade Gliomas.

Authors:  Ming Wang; Yan Cui; Yang Cai; Yugang Jiang; Yong Peng
Journal:  Cancer Manag Res       Date:  2021-06-29       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.